Xenograft of Human Umbilical Mesenchymal Stem Cells Promotes Recovery from Chronic Ischemic Stroke in Rats

Xenograft of Human Umbilical Mesenchymal Stem Cells Promotes Recovery from Chronic Ischemic Stroke in Rats

Stroke is a leading cause of adult disability. In our previous study, transplantation of human umbilical mesenchymal stem cells (HUMSCs) in Wharton’s jelly in the acute phase of ischemic stroke promotes recovery in rats. Unfortunately, there is no cure for chronic stroke. Patients with chronic strok...

Full description

Bibliographic Details
Main Authors:	Yu-Show Fu, Chang-Ching Yeh, Pei-Ming Chu, Wen-Hsing Chang, Maan-Yuh Anya Lin, Yung-Yang Lin
Format:	Article
Language:	English
Published:	MDPI AG 2022-03-01
Series:	International Journal of Molecular Sciences
Subjects:	chronic stroke cerebral ischemia umbilical mesenchymal stem cells Wharton’s jelly xenograft transplantation
Online Access:	https://www.mdpi.com/1422-0067/23/6/3149

Similar Items

Reversal of Pulmonary Fibrosis: Human Umbilical Mesenchymal Stem Cells from Wharton’s Jelly versus Human-Adipose-Derived Mesenchymal Stem Cells
by: Kuo-An Chu, et al.
Published: (2023-04-01)

Umbilical cord-derived mesenchymal stem cells cultured in the MCL medium for aplastic anemia therapy
by: Chuan He, et al.
Published: (2023-08-01)

Umbilical Cord-Derived Wharton’s Jelly for Regenerative Medicine Applications: A Systematic Review
by: Benjamin J. Main, et al.
Published: (2021-10-01)

Expression of reprogramming factors in mesenchymal stem cells isolated from equine umbilical cord Wharton’s jelly and amniotic fluid
by: N S RATHORE, et al.
Published: (2021-08-01)

Positive correlation between the quantity of Wharton’s jelly in the umbilical cord and birth weight
by: Avsar A. Filiz, et al.
Published: (2011-03-01)

Area of Wharton's jelly as an estimate of the thickness of the umbilical cord and its relationship with estimated fetal weight
by: Marussi Emilio F, et al.
Published: (2011-11-01)

Absence of Wharton’s Jelly at the Abdominal Site of the Umbilical Cord Insertion. Rare Case Report and Review of the Literature
by: Radu Botezatu, et al.
Published: (2021-11-01)

Gastroschisis Repair Technique using Autologous Umbilical Cord Flap in a Resource Limited Setup: Case Series
by: DILEEP GARG, et al.
Published: (2020-07-01)

Wharton’s jelly absence: a possible cause of stillbirth
by: Eduarda Bittencourt Damasceno, et al.
Published: (2013-12-01)

Wharton’s Jelly Mesenchymal Stem Cell: Various Protocols for Isolation and Differentiation of Hepatocyte-Like Cells; Narrative Review
by: Negar Varaa, et al.
Published: (2019-11-01)

Evaluation of the effect of an intradermal injection of Wharton\'s jelly-derived mesenchymal stem cells in diabetic wound healing in animal model
by: Sona Zare, et al.
Published: (2021-02-01)

Allogenic umbilical cord tissue for temporomandibular joint injuries
by: Adarsh Aratikatla, et al.
Published: (2023-10-01)

Mitochondrial activity of human umbilical cord mesenchymal stem cells
by: Blaise M Cozene, et al.
Published: (2021-01-01)

Application of Concentrated Growth Factors Membrane for Human Umbilical Cord Wharton’s Jelly Mesenchymal Stem Cell Differentiation towards Keratinocytes
by: Chao-Hsing Kao
Published: (2021-05-01)

In-vitro Differentiation of Human Umbilical Cord Wharton’s Jelly Mesenchymal Stem Cells to Insulin-Producing Cells
by: Masoomeh Nekohi Madoei, et al.
Published: (2015-04-01)

In-vitro Differentiation of Human Umbilical Cord Wharton’s Jelly Mesenchymal Stem Cells to Insulin-Producing Cells
by: Masoomeh Nekohi Madoei, et al.
Published: (2015-05-01)

Germline cells derived from mesenchymal stem cells, with the focus on Wharton's jelly
by: Hossein Yazdekhasti, et al.
Published: (2018-01-01)

The effects of umbilical cord Wharton jelly derived mesenchymal stem cells injection on diabetic wound healing in male rats
by: Mohammad Ali Nilforoushzadeh, et al.
Published: (2021-05-01)

The Potentiality of Human Umbilical Cord Isolated Mesenchymal Stem/Stromal Cells for Cardiomyocyte Generation [Corrigendum]
by: Abou-ElNaga A, et al.
Published: (2021-01-01)

Human Wharton’s Jelly—Cellular Specificity, Stemness Potency, Animal Models, and Current Application in Human Clinical Trials
by: Katarzyna Stefańska, et al.
Published: (2020-04-01)

Characterization of mesenchymal stem cells isolated from Wharton’s jelly of the human umbilical cord
by: Hager Abouelnaga, et al.
Published: (2022-01-01)

Defined three-dimensional culture conditions mediate efficient induction of definitive endoderm lineage from human umbilical cord Wharton’s jelly mesenchymal stem cells
by: Ashraf Al Madhoun, et al.
Published: (2016-11-01)

An optimized procedure for preparation of conditioned medium from Wharton’s jelly mesenchymal stromal cells isolated from umbilical cord
by: Santina Acuto, et al.
Published: (2023-10-01)

Umbilical cord-derived Wharton’s jelly for regenerative medicine applications in orthopedic surgery: a systematic review protocol
by: Benjamin J. Main, et al.
Published: (2020-11-01)

Human umbilical cord-derived mesenchymal stem/stromal cells: a promising candidate for the development of advanced therapy medicinal products
by: Miryam Mebarki, et al.
Published: (2021-02-01)

Expression of early transcription factors by mesenchymal stem cells derived from ovine umbilical cord Wharton’s jelly
by: S ESWARI, et al.
Published: (2016-10-01)

Umbilical cord-derived Wharton’s jelly for regenerative medicine applications
by: Ashim Gupta, et al.
Published: (2020-02-01)

Wharton' jelly mesenchymal stromal cell therapy for ischemic brain injury
by: Kuo-Jen Wu, et al.
Published: (2018-01-01)

Intravenous infusion of human umbilical cord Wharton’s jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia
by: Yingxin Zhang, et al.
Published: (2020-05-01)

Scale-Up of Academic Mesenchymal Stromal Cell Production
by: Caroline Laroye, et al.
Published: (2023-06-01)

The effect of amniotic membrane extract on umbilical cord blood mesenchymal stem cell expansion: is there any need to save the amniotic membrane besides the umbilical cord blood?
by: Zahra Vojdani, et al.
Published: (2016-01-01)

Assessment of the Neuroprotective and Stemness Properties of Human Wharton’s Jelly-Derived Mesenchymal Stem Cells under Variable (5% vs. 21%) Aerobic Conditions
by: Ewelina Tomecka, et al.
Published: (2021-03-01)

Umbilical Cord-Mesenchymal Stem Cell-Conditioned Medium Improves Insulin Resistance in C2C12 Cell
by: Kyung-Soo Kim, et al.
Published: (2021-03-01)

Treatment of Knee Osteoarthritis with Intraarticular Umbilical Cord-Derived Wharton’s Jelly: A Case Report
by: Ashim Gupta, et al.
Published: (2021-08-01)

Exosomes from acellular Wharton’s jelly of the human umbilical cord promotes skin wound healing
by: Nazihah Bakhtyar, et al.
Published: (2018-07-01)

VEGF Expression in Umbilical Cord MSC Depends on the Patient’s Health, the Week of Pregnancy in Which the Delivery Took Place, and the Body Weight of the Newborn – Preliminary Report
by: Bieńko K, et al.
Published: (2023-04-01)

Isolation and Characterization of Feline Wharton’s Jelly-Derived Mesenchymal Stem Cells
by: Min-Soo Seo, et al.
Published: (2021-02-01)

Combined intra-arterial and intra-muscular transfer of Wharton’s jelly mesenchymal stem/stromal cells in no-option critical limb ischemia – the CIRCULATE N-O CLI Pilot Study
by: Tomasz Kwiatkowski, et al.
Published: (2022-11-01)

Comparative Analysis of Mesenchymal Stem Cells Isolated from Human Bone Marrow and Wharton’s Jelly
by: Narges Talebian, et al.
Published: (2013-05-01)

Effects of umbilical cord tissue mesenchymal stem cells (UCX®) on rat sciatic nerve regeneration after neurotmesis injuries
by: Gärtner A, et al.
Published: (2013-04-01)